TTM
$1.09B
YoY change
-74.3%
5Y CAGR
+5.4%
Peak year (2024)
$4.17B
Cumulative net income
$16.90B
Net Income history chart for Edwards Lifesciences (EW) from 1999 to 2025
Latest: $1.07B
Net Income growth chart for Edwards Lifesciences (EW) from 1999 to 2025
Latest: -74.3%
Net Income history table for Edwards Lifesciences (EW) from 1999 to 2025
| 2025 | $1.07B | -74.3% | −$3.10B | ||
| 2024 | $4.17B | +197.7% | +$2.77B | ||
| 2023 | $1.40B | -7.9% | −$119.50M | ||
| 2022 | $1.52B | +1.3% | +$18.80M | ||
| 2021 | $1.50B | +82.5% | +$679.70M | ||
| 2020 | $823.40M | -21.3% | −$223.50M | ||
| 2019 | $1.05B | +45.0% | +$324.70M | ||
| 2018 | $722.20M | +16.1% | +$100.10M | ||
| 2017 | $622.10M | +9.2% | +$52.60M | ||
| 2016 | $569.50M | +15.1% | +$74.60M | ||
| 2015 | $494.90M | -39.0% | −$316.20M | ||
| 2014 | $811.10M | +107.1% | +$419.40M | ||
| 2013 | $391.70M | +33.6% | +$98.50M | ||
| 2012 | $293.20M | +23.9% | +$56.50M | ||
| 2011 | $236.70M | +8.6% | +$18.70M | ||
| 2010 | $218.00M | -4.8% | −$11.10M | ||
| 2009 | $229.10M | +77.7% | +$100.20M | ||
| 2008 | $128.90M | +14.1% | +$15.90M | ||
| 2007 | $113.00M | -13.4% | −$17.50M | ||
| 2006 | $130.50M | +64.6% | +$51.20M | ||
| 2005 | $79.30M | +4564.7% | +$77.60M | ||
| 2004 | $1.70M | -97.8% | −$77.30M | ||
| 2003 | $79.00M | +41.8% | +$23.30M | ||
| 2002 | $55.70M | -564.2% | +$67.70M | ||
| 2001 | −$12.00M | -95.6% | +$260.00M | ||
| 2000 | −$272.00M | -431.7% | −$354.00M | ||
| 1999 | $82.00M | — | — |
- 2025$1.07B-74.3%
- 2024$4.17B+197.7%
- 2023$1.40B-7.9%
- 2022$1.52B+1.3%
- 2021$1.50B+82.5%
- 2020$823.40M-21.3%
- 2019$1.05B+45.0%
- 2018$722.20M+16.1%
- 2017$622.10M+9.2%
- 2016$569.50M+15.1%
- 2015$494.90M-39.0%
- 2014$811.10M+107.1%
- 2013$391.70M+33.6%
- 2012$293.20M+23.9%
- 2011$236.70M+8.6%
- 2010$218.00M-4.8%
- 2009$229.10M+77.7%
- 2008$128.90M+14.1%
- 2007$113.00M-13.4%
- 2006$130.50M+64.6%
- 2005$79.30M+4564.7%
- 2004$1.70M-97.8%
- 2003$79.00M+41.8%
- 2002$55.70M-564.2%
- 2001−$12.00M-95.6%
- 2000−$272.00M-431.7%
- 1999$82.00M—
Net Income values are taken from Edwards Lifesciences's reported income statements (quarterly 10-Q and annual 10-K filings with the U.S. Securities and Exchange Commission). Each row shows the period end date and the filing date. YoY compares each figure to the same period one year earlier. Amounts are in USD as filed.
About Net Income at Edwards Lifesciences (EW)
According to Edwards Lifesciences's latest reported financial statements, the company's current net income (TTM) is $1.09B. Net income is the bottom-line profit after all expenses — cost of goods sold, operating expenses, interest, and taxes — are subtracted from revenue. It is the figure used to compute earnings per share (EPS) and is the residual available to shareholders.
Headline TTM above sums the four reported quarters through (reported ). Chart and table below cover the full reported history back to .
The 2025 reading of Edwards Lifesciences (EW) net income is $1.07B – plunged 74.3% year-over-year.
Across 2020–2025 (5 years), Edwards Lifesciences net income produced a CAGR of +5.4% – with mixed annual results across the window.
Between 2024 and 2025, Edwards Lifesciences net income plunged 74.3%, falling from $4.17B to $1.07B.
2024 marks the peak net income at $4.17B, with the historical low of −$272.00M recorded in 2000.
Edwards Lifesciences Net Income by Year
Edwards Lifesciences Net Income 2025: $1.07B
In 2025, Edwards Lifesciences reported net income of $1.07B, plunged 74.3% below 2024.
Edwards Lifesciences Net Income 2024: $4.17B
Edwards Lifesciences net income in 2024 was $4.17B, surged 197.7% from 2023. This figure represents the highest annual value in the available history.
Edwards Lifesciences Net Income 2023: $1.40B
2023's net income for Edwards Lifesciences came in at $1.40B, declined 7.9% below 2022.
Edwards Lifesciences Net Income 2022: $1.52B
Edwards Lifesciences posted net income of $1.52B in 2022, edged up 1.3% from 2021.
Edwards Lifesciences Net Income 2021: $1.50B
Edwards Lifesciences net income in 2021 was $1.50B.
See more financial history for Edwards Lifesciences (EW).
Sector peers by Net Income
Healthcare peers of Edwards Lifesciences (EW), ranked by their latest net income
| $26.80B | |
| $20.64B | |
| $18.25B | |
| $15.97B | |
| $12.06B | |
| $10.26B | |
| $7.71B | |
| $4.23B |
- $26.80B
- $20.64B
- $18.25B
- $15.97B
- $12.06B
- $10.26B
- $7.71B
- $4.23B
Frequently asked questions
Edwards Lifesciences (EW) Key Financials
Charts, filings, and peer comparison for every metric
Explore more
Deep-dives across the income statement, cash flow, capital return, and valuation